These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10609872)

  • 1. Oxidative stress in hemodialysis patients treated with a dialysis membrane which has alpha-tocopherol bonded to its surface.
    Sommerburg ; Sostmann K; Grune T; Ehrich JH
    Biofactors; 1999; 10(2-3):121-4. PubMed ID: 10609872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
    Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E-Bonded Membranes Do Not Influence Markers of Oxidative Stress in Hemodialysis Patients with Homozygous Glutathione Transferase M1 Gene Deletion.
    Djuric P; Suvakov S; Simic T; Markovic D; Jerotic D; Jankovic A; Bulatovic A; Tosic Dragovic J; Damjanovic T; Marinkovic J; Naumovic R; Dimkovic N
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.
    MacGinley R; Westhuyzen J; Saltissi D; Morgan C; Healy H; Thirlwell GK; Disney AP
    ASAIO J; 2001; 47(1):66-73. PubMed ID: 11199319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
    Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
    Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
    Westhuyzen J; Saltissi D; Stanbury V
    Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients.
    Triolo L; Malaguti M; Ansali F; Comunian MC; Arcangeloni O; Coppolino F; Marrocco F; Sicoli R; Biagini M
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):185-91. PubMed ID: 12751839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis--a molecular biological approach.
    Calò LA; Naso A; Pagnin E; Davis PA; Castoro M; Corradin R; Riegler P; Cascone C; Huber W; Piccoli A
    Clin Nephrol; 2004 Nov; 62(5):355-61. PubMed ID: 15571180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and cardiovascular disease in dialyzed patients.
    Usberti M; Gerardi GM; Gazzotti RM; Benedini S; Archetti S; Sugherini L; Valentini M; Tira P; Bufano G; Albertini A; Di Lorenzo D
    Nephron; 2002 May; 91(1):25-33. PubMed ID: 12021516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
    Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
    Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
    Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients.
    Mune M; Yukawa S; Kishino M; Otani H; Kimura K; Nishikawa O; Takahashi T; Kodama N; Saika Y; Yamada Y
    Kidney Int Suppl; 1999 Jul; 71():S126-9. PubMed ID: 10412755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia.
    Siems W; Carluccio F; Grune T; Jakstadt M; Quast S; Hampl H; Sommerburg O
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S20-5. PubMed ID: 12227722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.